20 Chen J, Han M, Liu A, et al
But in the group receiving retatrutide, metabolism did not drop in the same way
The primary allegation against Belcher was wrongful discharge based on matter [sic] unrelated to Belcher and issues related to Mihir Taneja were unrelated to Belcher/BPI
Here is what most sources will not tell you
Lead author, Professor Thomas Foltynie (UCL Queen Square Institute of Neurology) said: The results of this trial have been eagerly anticipated and the negative results will be a major disappointment to patients affected by Parkinsons disease and the Parkinsons disease research community. GLP-1 drugs such as semaglutide (Wegovy) and Ozempic - have become increasingly popular over recent years and there has been an enormous interest in their potential health benefits
Post-Marketing Reports and Real-World Data After a medication is approved and used by the general population, its manufacturer and healthcare authorities continue to monitor safety through post-marketing surveillance